Genome-wide analysis of DNA methylation and their associations with long noncoding RNA/mRNA expression in non-small-cell lung cancer.
暂无分享,去创建一个
Yu Wang | Lana Garmire | Herbert Yu | Xiangqian Zheng | Biyun Qian | B. Qian | Herbert Yu | L. Garmire | Xiangqian Zheng | Nannan Feng | Yu Wang | M. Zheng | X. Yu | Hongyan Lin | Rongna Ma | O. Shi | Ming Gao | Oumin Shi | Nannan Feng | Min Zheng | Xiao Yu | Hongyan Lin | Rong-Na Ma | Ming Gao | X. Yu | Mingjun Zheng | Oumin Shi
[1] Dirk Schadendorf,et al. Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma. , 2011, Carcinogenesis.
[2] G. Lang,et al. Genome-wide CpG island methylation analyses in non-small cell lung cancer patients. , 2013, Carcinogenesis.
[3] Ludmila V. Danilova,et al. Frequent Inactivation of Cysteine Dioxygenase Type 1 Contributes to Survival of Breast Cancer Cells and Resistance to Anthracyclines , 2013, Clinical Cancer Research.
[4] J. Foekens,et al. RESEARCH ARTICLE Open Access Research article CDO1 Promoter Methylation is a Biomarker for Outcome Prediction of Anthracycline Treated, Estrogen Receptor-Positive, Lymph Node-Positive Breast Cancer Patients , 2022 .
[5] K. Tozawa,et al. GPX2 overexpression is involved in cell proliferation and prognosis of castration-resistant prostate cancer. , 2014, Carcinogenesis.
[6] C. Plass,et al. Long noncoding RNA TARID directs demethylation and activation of the tumor suppressor TCF21 via GADD45A. , 2014, Molecular cell.
[7] J. Adrian Gillet,et al. Cancer diagnosis and prognosis , 1969 .
[8] D. Dai,et al. Protein expression and promoter methylation of the candidate biomarker TCF21 in gastric cancer , 2015, Journal of Cancer Research and Clinical Oncology.
[9] Jingcheng Yang,et al. Analysis of lncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes. , 2014, Lung cancer.
[10] Xiao-shu Hu,et al. Expression of esophageal carcinoma related gene 4 (ECRG4) and its clinical significance in prognosis of esophageal carcinoma. , 2015, International journal of clinical and experimental pathology.
[11] E. Petricoin,et al. Integrated Genomic and Epigenomic Analysis of Breast Cancer Brain Metastasis , 2014, PloS one.
[12] J. Mao,et al. C2ORF40 suppresses breast cancer cell proliferation and invasion through modulating expression of M phase cell cycle genes , 2013, Epigenetics.
[13] C. Rudack,et al. Protein expression and promoter methylation of the candidate biomarker TCF21 in head and neck squamous cell carcinoma , 2013, Cellular Oncology.
[14] J. Herman,et al. Functional Identification of Cancer-Specific Methylation of CDO1, HOXA9, and TAC1 for the Diagnosis of Lung Cancer , 2014, Clinical Cancer Research.
[15] Kang Jin Jeong,et al. Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients. , 2011, Cancer letters.
[16] N. Hacohen,et al. The scavenger receptor SCARF 1 mediates the clearance of apoptotic cells and prevents autoimmunity , 2022 .
[17] I. B. Borel Rinkes,et al. GPx2 suppression of H2O2 stress links the formation of differentiated tumor mass to metastatic capacity in colorectal cancer. , 2014, Cancer research.
[18] B. Karlan,et al. A Collagen-Remodeling Gene Signature Regulated by TGF-β Signaling Is Associated with Metastasis and Poor Survival in Serous Ovarian Cancer , 2013, Clinical Cancer Research.
[19] H. Kędzierska,et al. Expression of Genes Involved in Cellular Adhesion and Extracellular Matrix Remodeling Correlates with Poor Survival of Patients with Renal Cancer. , 2016, The Journal of urology.
[20] R. Lothe,et al. TCF21 and PCDH17 methylation: An innovative panel of biomarkers for a simultaneous detection of urological cancers , 2011, Epigenetics.
[21] J. Déjardin,et al. End-targeting proteomics of isolated chromatin segments of a mammalian ribosomal RNA gene promoter , 2015, Nature Communications.
[22] Roberto Incitti,et al. Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer , 2013, BMC Cancer.
[23] Hiromu Suzuki,et al. A genomic screen for long noncoding RNA genes epigenetically silenced by aberrant DNA methylation in colorectal cancer , 2016, Scientific Reports.
[24] J. Tost,et al. Complete pipeline for Infinium(®) Human Methylation 450K BeadChip data processing using subset quantile normalization for accurate DNA methylation estimation. , 2012, Epigenomics.
[25] Jin-Haeng Chung,et al. DNA methylation profile during multistage progression of pulmonary adenocarcinomas , 2011, Virchows Archiv.
[26] Yair Lotan,et al. Detection of Bladder Cancer Using Novel DNA Methylation Biomarkers in Urine Sediments , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[27] Y. Xi,et al. Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer. , 2008, Oncology reports.
[28] P. Laird,et al. Genome-Scale Screen for DNA Methylation-Based Detection Markers for Ovarian Cancer , 2011, PloS one.
[29] S. Ropero,et al. A DNA hypermethylation profile reveals new potential biomarkers for the evaluation of prognosis in urothelial bladder cancer , 2017, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[30] Z. Cai,et al. Down-regulation of TCF21 is associated with poor survival in clear cell renal cell carcinoma. , 2012, Neoplasma.
[31] Peiyong Jiang,et al. Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing , 2013, Proceedings of the National Academy of Sciences.
[32] J. Hesketh,et al. Selenium alters miRNA profile in an intestinal cell line: evidence that miR-185 regulates expression of GPX2 and SEPSH2. , 2013, Molecular nutrition & food research.
[33] B. Qian,et al. Analysis of Microarray Data on Gene Expression and Methylation to Identify Long Non-coding RNAs in Non-small Cell Lung Cancer , 2016, Scientific Reports.
[34] W. Gerald,et al. A Genome-Wide Screen for Promoter Methylation in Lung Cancer Identifies Novel Methylation Markers for Multiple Malignancies , 2006, PLoS medicine.
[35] D. Deng,et al. Expression of ECRG4, a novel esophageal cancer-related gene, downregulated by CpG island hypermethylation in human esophageal squamous cell carcinoma. , 2003, World journal of gastroenterology.
[36] Christoph Plass,et al. Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[37] Xiao-yan Li,et al. A novel tumor suppressor gene ECRG4 interacts directly with TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal carcinoma , 2011, BMC Cancer.
[38] D. Spector,et al. Long noncoding RNAs: functional surprises from the RNA world. , 2009, Genes & development.
[39] Mihaela Campan,et al. Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancer , 2008, Molecular Cancer.
[40] Z. Dong,et al. Aberrant methylation-mediated downregulation of long noncoding RNA LOC100130476 correlates with malignant progression of esophageal squamous cell carcinoma. , 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[41] S. Zöchbauer-Müller,et al. Lung cancer: From single-gene methylation to methylome profiling , 2010, Cancer and Metastasis Reviews.
[42] B. Stillman,et al. Orc6 Involved in DNA Replication, Chromosome Segregation, and Cytokinesis , 2002, Science.